Immune checkpoint inhibitors increase the risk of hypothyroidism in patients with primary head and neck cancer compared to other cancers

被引：0
|
作者：
Alaber, Omar [1 ]
Chandar, Apoorva [1 ]
Mendiratta, Prateek [1 ]
Patel, Monaliben [1 ]
Hoimes, Chris [1 ]
Lavertu, Pierre [1 ]
Mangla, Ankit [1 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P710
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Increased risk of hypothyroidism in patients with primary head and neck cancer compared to non-head and neck primary malignancies
    Alaber, Omar A.
    Chander, Apoorva K.
    Jain, Prantesh
    Rajpal, Aman
    Patel, Monaliben
    Hoimes, Christopher J.
    Mendiratta, Prateek
    Lavertu, Pierre
    Mangla, Ankit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [2] Emerging immune checkpoint inhibitors for the treatment of head and neck cancers
    Green, Sarah E.
    McCusker, Michael G.
    Mehra, Ranee
    EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (04) : 501 - 514
  • [3] Comorbid Depression in Patients With Head and Neck Cancer Compared With Other Cancers
    Martinez, Marina C.
    Finegersh, Andrey
    Baik, Fred M.
    Holsinger, F. Chris
    Starmer, Heather M.
    Orloff, Lisa A.
    Sunwoo, John B.
    Sirjani, Davud
    Divi, Vasu
    Chen, Michelle M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024, 150 (12) : 1097 - 1104
  • [4] Immune checkpoint inhibitors in patients with cancers of unknown primary
    Rassy, Elie
    Karam, Elias
    Adeleke, Sola
    Okoli, Somto
    Galante, Joao
    Boussios, Stergios
    Pavlidis, Nicholas
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [5] Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors
    Leddon, Jennifer L.
    Chirra, Martina
    Frankart, Andrew J.
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha M.
    LARYNGOSCOPE, 2021, 131 (07): : E2413 - E2419
  • [6] Immune Checkpoint Therapy in Head and Neck Cancers
    Msaouel, Pavlos
    Massarelli, Erminia
    CANCER JOURNAL, 2016, 22 (02): : 108 - 116
  • [7] Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
    Elbehi, Attia M.
    Anu, R., I
    Ekine-Afolabi, Bene
    Cash, Elizabeth
    ORAL ONCOLOGY, 2020, 109
  • [8] Rational Combinations of Targeted Therapy and Immune Checkpoint Inhibitors in Head and Neck Cancers
    Chai, Annie Wai Yeeng
    Yee, Pei San
    Cheong, Sok Ching
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
    Ettl, Tobias
    Grube, Matthias
    Schulz, Daniela
    Bauer, Richard Josef
    CANCERS, 2022, 14 (20)
  • [10] Checkpoint inhibitors in head and neck cancer
    Ilson Sepulveda
    Rodrigo Ascui
    A. Andrés Capizzano
    memo - Magazine of European Medical Oncology, 2019, 12 : 249 - 252
12345